mpMRI

State-of-the-art MRI technology bypasses need for kidney biopsy

The most common type of tumor found in the kidney is generally quite small (less than 1.5 in). These tumors are usually found by accident when CAT scans are performed for other reasons and the serendipitous finding poses a problem for doctors.

Are these tumors malignant and do they need to be surgically removed because they may threaten the patient’s life? Or are they benign and can be left alone? The decision is often made with a biopsy. By sampling the tumor, doctors are able to determine whether the cancer is benign or malignant. However, biopsies are invasive procedures and not without risks. Investigators with the Kidney Cancer Program at UT Southwestern Harold C. Simmons Comprehensive Cancer Center have developed a Magnetic Resonance Imaging (MRI) technology that can provide information about the nature and aggressiveness of the cancer without having to perform a biopsy.

If we can avoid the anxiety and the fear and the rare, but possible complication of a biopsy, I think we’re pushing medicine forward

Jeffrey Cadeddu

The team, led by Drs. Ivan Pedrosa and Jeffrey Cadeddu, co-authors of the study highlighted on the cover of The Journal of Urology, have developed multiparametric MRI (mpMRI) protocols that tell physicians with high confidence whether the tumor is aggressive or not. These protocols allow investigators to evaluate the chemical composition of the tumor without a biopsy. This composition allows doctors to infer what type of cancer it is. “Using mpMRI, multiple types of images can be obtained from the renal mass and each one tells us something about the tissue,” said Dr. Ivan Pedrosa, Professor of Radiology and Chief of Magnetic Resonance Imaging.

The standardized diagnostic algorithm is largely based on the appearance of the renal mass on specific MRI images, namely T2-weighted images and those immediately after intravenous (IV) dye reaches the kidney. Other images are also used that indicate whether fat is present in the tumor. Based on the algorithm, physicians can recognize clear cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer, with 80% confidence. “Using mpMRI, doctors at UT Southwestern have a four-in-five chance of identifying clear cell cancer” said Dr. Pedrosa.

The data collected from this study support the use of mpMRI to reduce the number of biopsies. “Biopsies are not entirely free of pain and discomfort,” said Dr. Cadeddu, Professor of Urology and Radiology at UT Southwestern. “Some patients, in fact, choose to observe the cancer simply to avoid the pain of the biopsy,” he says. Investigators at UT Southwestern continue to push the technology and are hoping in the near future to be able to predict not only the type of cancer, but also to tell how aggressive it is. “If we can avoid the anxiety and the fear and the rare, but possible complication of a biopsy, I think we’re pushing medicine forward,” said Dr. Cadeddu.


Source: UT Southwestern Medical Center

03.01.2018

Read all latest stories

Related articles

Breast cancer

New imaging technique to ensure surgeons completely remove cancer

Of the quarter-million women diagnosed with breast cancer every year in the United States, about 180,000 undergo surgery to remove the cancerous tissue while preserving as much healthy breast tissue…

Comfort

Value in an open platform

As Hitachi deploys its new generation of Oasis 1.2-T MRI scanners throughout Europe, our Madrid correspondent asked Dr Manuela Jorquera Moya about her experiences with the new scanner over the past…

Head and Neck Radiology

The Radiologist’s Fear of Spaces

Imaging the head and neck is only rarely practised in radiology training and is highly complex and particulate, which is why, during our discussion with Professor Birgit Ertl-Wagner, Head of MRI at…

Related products